January 14, 2021, via Zoom webinar With two vaccines approved for emergency use in the U.S., the next major hurdle in the fight against the pandemic will be getting people immunized. In the U.S. alone, distributing vaccines to over 300 million people will present an unprecedented logistical challenge. The accelerated pace of vaccines development has also given rise to many questions and unease among the public. Moderator Alex Knapp, Senior Editor of Healthcare and Science at Forbes, leads a discussion with Dr. Kelly Moore about COVID-19 vaccines, including their safety, effectiveness, and distribution process. Speakers: Alex Knapp is a Senior Editor at Forbes, where he manages coverage of healthcare and science topics. He writes about a wide variety of topics related to the intersection of science and business, including healthcare, the commercial space industry, and quantum computing. He also edits the Forbes’ “30 Under 30 Science and Healthcare” lists as well as Forbes’ “Europe 30 Under 30 list for Industry & Manufacturing. Kelly Moore, MD, MPH, is Deputy Director of Immunization Action Coalition (IAC) and an adjunct associate professor in the Department of Health Policy at Vanderbilt University. The IAC works to increase immunization rates and facilitates communication about the safety, efficacy, and use of vaccines within the broad immunization community of patients, parents, healthcare organizations, and government health agencies. For more than two decades, the CDC has worked in concert with and provided financial support to IAC for the purpose of educating healthcare professionals about U.S. vaccine recommendations.

Be the first to comment